In the video below, Motley Fool health-care analyst Max Macaluso takes a question from a Fool reader, who asks, "What do you think of AbbVie (ABBV 0.93%)?"
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Ask a Fool: What Do You Think About AbbVie?
By Max Macaluso
–
May 30, 2013 at 7:50PM
NYSE: ABBV
AbbVie
Market Cap
$330B
Today's Change
(0.93%) $1.73
Current Price
$187.12
Price as of June 26, 2025, 3:58 p.m. ET
AbbVie has generated a lot of buzz in the pharmaceuticals space ever since it spun off from Abbott Labs. What do we think of it here at the Fool?
Max Macaluso, Ph.D. and The Motley Fool have no position in any stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
AbbVie
ABBV
$187.12
(0.93%)
$1.73
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
3 Cheap Dividend Growth Stocks to Buy Right Now
2 Incredible Dividend Growth Stocks to Buy Now
3 Magnificent Stocks That Are Passive Income Machines
Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.